Explore the microbiota related to Extramammary Paget's Disease and its interaction with the host.

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000037046

Enrollment

Unknown

Registered

2020-08-26

Start date

2020-10-20

Completion date

Unknown

Last updated

2020-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Extramammary Paget’s Disease

Interventions

EMPD lesion site group vs. Autogenous normal site group:

Eligibility

Sex/Gender

All

Age

35 Years to 85 Years

Inclusion criteria

Inclusion criteria: a. Preoperative case biopsy confirmed as primary EMPD; b. Acceptable examination; c. Signed informed consent for surgical treatment and approved by the Ethics Committee of Shanghai Dermatology Hospital. d. Age from 35 to 85 years old, no active infectious diseases, blood system diseases.

Exclusion criteria

Exclusion criteria: a. Patients with secondary bacterial infections of the tumor; b. Patients with severe medical or infectious diseases; c. Participation in other clinical studies recently; d. Incomplete data.

Design outcomes

Primary

Measure	Time frame
structure and composition of microflora;	—

Countries

China

Contacts

Public ContactJianna Yan

Department of Dermatology, Shanghai Skin Diseases Hospital

everything5254@163.com+86 18017336570

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026